UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
_______________________

FORM 10-Q
_______________________
(Mark One)
xQuarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended March 31, 20162017

or
 
¨Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from___________ to ____________
      
Commission file number 000-52622

GREEN PLANET BIOENGINEERING CO., LTD.
(Exact Name of Registrant as Specified in its charter)
 
Delaware
37-1532842
(State or other jurisdiction of incorporation or organization)
 (I.R.S. EmployerIdentification(I.R.S. Employer Identification No.)
 
20807 Biscayne Blvd., Suite 203,
Aventura, Florida
33180
 (Address(Address of principal executive offices)
(Zip Code)

(305) 328-8662(786) 279-2900
(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x     No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes ¨    No ¨

Indicate by checkmarkcheck mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer” and, “smaller reporting company” and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer
 o
Accelerated filer
 o
Non-accelerated filer
 o
☐  (Do not check if a smaller reporting company)
Smaller reporting company
 x
☒ 
Emerging growth company
(DoIf an emerging growth company, indicate by check mark if the registrant has elected not check if a smaller company)

to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐  
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes x  No  ¨
 
The number of shares of common stock outstanding as of May 13, 201615, 2017 was 20,006,402.
 

 

 
TABLE OF CONTENTS
 

Page Number
PART I    FINANCIAL INFORMATION
Page
 
Item 1.Financial Statements1
Condensed Balance Sheets as of March 31, 2017 (Unaudited) and December 31, 20161
   
 4
Condensed Balance Sheets as of March 31, 2016 (Unaudited) and December 31, 20154
Condensed Statements of Operations for the Three Months EndedMarch 31, 20162017 and 2015201652
   
 63
   
 74
   
96
   
7
10
   
107
   
PART II    OTHER INFORMATION
 
   
118
   
118
   
118
   
118
   
118
   
118
   
SIGNATURES SIGNATURES129-11

 
i
2

 
 
INTERIM FINANCIAL STATEMENTS

The unaudited interim financial statements have been prepared in accordance with generally accepted accounting principles in the United States for interim financial information and with the instructions under Regulation S-X of the Securities and Exchange Commission (“SEC”) Form 10-Q. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. Therefore, these financial statements should be read in conjunction with the Company’s audited financial statements and notes thereto for the year ended December 31, 2015.2016.

The financial statements included herein are unaudited; however, they contain all normal recurring accruals and adjustments that, in the opinion of management, are necessary to present fairly the Company’s financial position as of the period reporting date, and the results of its operations and cash flows for the fiscal period end. The results of operations for the fiscal period end are not necessarily indicative of the results to be expected for future quarters or the full fiscal year.


 FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934.statements. These statements involve risks and uncertainties, including, among other things, statements regarding our business strategy, future revenues and anticipated costs and expenses. Such forward-looking statements include, among others, those statements including the words “expects,” “anticipates,” “intends,” “believes,” “may,” “will,” “should,” “could,” “plans,” “estimates,” and similar language or negative of such terms. Our actual results may differ significantly from those projected in the forward-looking statements. Factors that might cause or contribute to such differences include, but are not limited to, those discussed in Item 2 “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” You are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date of this report. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we do not know whether we can achieve positive future results, levels of activity, performance, or goals. Actual events or results may differ materially. We undertake no obligation to publicly release any revisions to the forward-looking statements or reflect events or circumstances taking place after the date of this document.
 
 
ii
3

 
 
PART IFINANCIAL INFORMATION
PART I 

FINANCIAL INFORMATION
FINANCIAL STATEMENTS
 
Condensed Balance Sheets
 
 March 31,  December 31, 
 
March 31,
 
 
December 31,
 
 2016  2015 
 
2017
 
 
2016
 
 (Unaudited)    
 
(Unaudited)
 
 
 
 
ASSETS      
 
 
 
Current assets      
 
 
 
Cash and cash equivalents $-  $- 
 $- 
TOTAL CURRENT ASSETS / TOTAL ASSETS $-  $- 
TOTAL CURRENT ASSETS
 $- 
LIABILITIES AND STOCKHOLDERS’ DEFICIT        
    
LIABILITIES        
    
Current liabilities        
    
Accounts payable $-  $- 
 $-
 
 $- 
Accrued liabilities $6,450  $11,450 
  6,500 
  11,500 
Amount due to a related party $147,303  $136,311 
  183,024
 
  171,914
 
TOTAL CURRENT LIABILITIES / TOTAL LIABILITIES $153,753  $147,761 
TOTAL CURRENT LIABILITIES
  189,524
 
  183,414
 
STOCKHOLDERS’ DEFICIT        
    
Preferred stock: par value of $0.001 per share        
    
Authorized: 10,000,000 shares at March 31, 2016 and December 31, 2015        
Issued and outstanding: 0 shares at March 31, 2016 and December 31, 2015  -   - 
Authorized: 10,000,000 shares at March 31, 2017 and December 31, 2016
    
Issued and outstanding: 0 shares at March 31, 2017 and December 31, 2016
  - 
Common stock: par value of $0.001 per share        
    
Authorized: 250,000,000 shares at March 31, 2016 and December 31, 2015     
Issued and outstanding: 20,006,402 shares at March 31, 2016 and        
31-Dec-15 $20,006  $20,006 
Authorized: 250,000,000 shares at March 31, 2017 and December 31, 2016
    
Issued and outstanding: 20,006,402 shares at March 31, 2017 and December 31, 2016
  20,006 
Additional paid-in-capital $609,614  $609,614 
  609,614 
Accumulated deficit $(783,373) $(777,381)
  (819,144)
  (813,034)
TOTAL STOCKOLDERS’ DEFICIT $(153,753) $(147,761)
  (189,524)
  (183,414)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT $-  $- 
  - 
 
See Notes to the Condensed Financial Statements

4

Condensed Statements of Operations
(Unaudited)
(Unaudited)
 
 
Three months ended March 31,
 
 
 
2017
 
 
2016
 
 
 
 
 
 
 
 
Administrative expenses
 $(6,110)
 $(5,992)
Loss before income taxes
  (6,110)
  (5,992)
Provision for income taxes
  - 
  - 
Net loss
 $(6,110)
 $(5,992)
Earnings per share
    
    
-Basic and diluted
 $* 
 $* 
Weighted average number of shares outstanding
    
    
-Basic and diluted
  20,006,402 
  20,006,402 
 
*
  Three months ended March 31, 
  2016  2015 
Administrative expenses $(5,992) $(5,027)
Loss before income taxes $(5,992) $(5,027)
Provision for income taxes  -   - 
Net loss $(5,992) $(5,027)
         
Earnings per share        
Basic and diluted $*  $* 
Weighted average number of shares outstanding        
Basic and diluted $20,006,402  $20,006,402 
* Less than $.01, per share
See Notes to the Condensed Financial Statements
5

Condensed Statements of Cash Flows
(Unaudited)
  
Three months ended March 31,
 
  2016  2015 
Cash flows from operating activities      
Net loss $(5,992) $(5,027)
Changes in operating assets and liabilities:        
Accounts payable  -  $490 
Accrued liabilities $(5,000) $(5,574)
Amount due to a related party $10,992  $10,111 
Net cash flows used by operating activities  -   - 
         
Cash flows from investing activities  -   - 
         
Cash flows from financing activities  -   - 
         
Net decrease in cash and cash equivalents  -   - 
Cash and cash equivalents – beginning of period  -   - 
Cash and cash equivalents – end of period $-  $- 
Supplemental disclosures for cash flow information:        
Cash paid for interest $-  $- 
Cash paid for income taxes $-  $- 
 
See Notes to the Condensed Financial Statements


 
Green Planet Bioengineering Co., Ltd.
6Condensed Statements of Cash Flows

(Unaudited)
 
 
 
Three months ended March 31,
 
 
 
2017
 
 
2016
 
Cash flows from operating activities
 
 
 
 
 
 
Net loss
 $(6,110)
 $(5,992)
Changes in operating assets and liabilities:
    
    
Accounts payable
  -
 
    
Accrued liabilities
  (5,000)
  (5,000)
Amount due to a related party
  11,110
 
  10,992 
Net cash flows used by operating activities
  - 
  - 
 
    
    
Cash flows from investing activities
  - 
  - 
 
    
    
Cash flows from financing activities
  - 
  - 
 
    
    
Net decrease in cash and cash equivalents
  - 
  - 
Cash and cash equivalents – beginning of period
  - 
  - 
Cash and cash equivalents – end of period
 $- 
 $- 
Supplemental disclosures for cash flow information:
    
    
Cash paid for interest
 $- 
 $- 
Cash paid for income taxes
 $- 
 $- 
See Notes to the Condensed Financial Statements


Notes to the Condensed Financial Statements
(Unaudited)

1. General Information

Mondo Acquisition II, Inc. was incorporated in the State of Delaware on October 30, 2006 and changed the name was changed to Green Planet Bioengineering Co., Ltd. (“Company”) on October 2, 2008. In October 2008, the Company acquired Elevated Throne Overseas Ltd, incorporated in British Virgin Islands, and its subsidiaries which was subsequently divested to One Bio, Corp (“ONE”) on April 14, 2010.

In March 2012, the Company became a subsidiary of Global Fund Holdings Corp. (“Global Funds”) an Ontario, Canada Corporation.

The Company operates as a public organizedreorganized shell corporation with the purpose to acquire or merge with an existing business operation. The Company's activities are subject to significant risks and uncertainties, as their ability to implement and execute future business plans and generate sufficient business revenue is directly influenced by their ability to secure adequate financing or find profitable business opportunities.

2. Summary of significant accounting policies

Basis of Presentation
The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and are unaudited; however, they contain all normal recurring accruals and adjustments that, in the opinion of management, are necessary to present fairly the Company’s financial position as of the period reporting date, and the results of its operations and cash flows for the fiscal period end. The results of operations for the fiscal period end are not necessarily indicative of the results to be expected for future quarters or the full fiscal year.

Use of Estimates
The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses for the years reported. Actual results could differ from those estimates. Significant items that require estimates were accruals of liabilities.

Cash and cash equivalents
Cash and cash equivalents include all cash, deposits in banks and other highly liquid investments with initial maturities of three months or less to be cash equivalents. Balances of cash and cash equivalents in financial institutions may at times exceed the government-insured limits.

Earnings per share
Earnings per share is reported in accordance with FASB ASC Topic 260 “Earnings per Share” which requires dual presentation of basic earnings per share (“EPS”) and diluted EPS on the face of all statements of earnings, for all entities with complex capital structures. Diluted EPS reflects the potential dilution that could occur from common shares issuable through the exercise or conversion of stock options, restricted stock awards, warrants and convertible securities. In certain circumstances, the conversion of these options, warrants and convertible securities are excluded from diluted EPS if the effect of such inclusion would be anti-dilutive. Fully diluted EPS is not provided, when the effect is anti-dilutive. When the effect of dilution on loss per share is anti-dilutive, diluted loss per share equals the loss per share.

Fair Value Measurements
FASB ASC Topic 820, “Fair Value Measurements and Disclosures” defines fair value, establishes a framework for measuring fair value in accordance with U.S. GAAP, and expands disclosures about fair value measurements. Investment measured and reported at fair value are classified and disclosed in one of the following hierarchy:

Level 1 - Quoted prices are available in active markets for identical investments as of the period reporting date.

2. Summary of Significant Accounting Policies – continued
Level 2 - Pricing inputs are other than quoted prices in active markets, which are either directly or indirectly observable as of the reporting date, and fair value is determined through the use of models or other valuation methodologies.
 
7

2. Summary of Significant Accounting Policies – continued

Level 3 - Pricing inputs are unobservable for the investment and included situations where there is little, if any, market activity for the investment. The inputs into the determination of fair value require significant management judgment or estimation.
 
Recent Changes in Accounting Standards
A varietyIn August 2014, the FASB issued ASU No. 2014-15 "Presentation of proposed or otherwise potential accounting standardsFinancial Statements-Going Concern." The provisions of ASU No.2014-15 require management to assess an entity’s liability to continue as a going concern by incorporating and expanding upon certain principles that are currently under study by standard-setting organizations and various regulatory agencies. Becausein U.S. audit standards. Specifically, the amendments (1) provide a definition of the tentativeterm substantial doubt, (2) require evaluation of every reporting period including interim periods, (3) provide principles for considering the mitigating effect of management’s plans, (4) require certain disclosures when substantial doubt is alleviated as a result of consideration of management’s plans, (5) require an express statement and preliminary natureother disclosures when substantial doubt in not alleviated, and (6) require an assessment for a period of these proposed standards, management hasone year after the date that the financial statements are issued (or available to be issued).  The amendments in this ASU are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. The Company believes that the adoption of ASU No. 2014-15 does not determined whether implementation of such proposed standardshave a material impact on the Company’s financial statements.
Management does not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would behave a material toeffect on the Company’saccompanying financial statements.
 
3. Going Concern

The financial statements have been prepared assuming that the Company will continue as a going concern. The Company is currently a public reorganized shell corporation and has no current business activity. The Company’s ability to continue as a going concern is dependent on continued support from Global Funds, the majority stockholder.
 
4. Amount Due to a Related Company

The Company relies on a related company to advance funds to finance its operating expenses. The amounts advanced are interest-free, unsecured and are repayable upon demand.
 
5. Preferred stock / Common stock

Series A Preferred stock
The Company is authorized under its Articles of Incorporation to issue 10,000,000 shares of Series A preferred stock with a par value of $0.001 per share. Each share of the Company’s preferred stock provides the holder with the right to vote 1,000 votes on all matters submitted to a vote of the stockholders of the Company and is convertible into 1,000 shares of the Company’s common stock. The preferred stock is non-participating and carries no dividend.

The company does not have any issued shares of the preferred stock as of March 31, 2017 and 2016.
Common stock
The Company is authorized to issue 250,000,000 shares of common stock with a par value of $0.001 per share. During the three months ended March 31, 2016,2017, the Company did not issue any shares of common stock or warrants.

6. Stock-based compensation

There was no non-cash stock-based compensation recognized for the three months ended March 31, 20162017 and 2015.2016.
 

 
8



General Overview

The Company operates as a public reorganized corporation with the business purpose to acquire or merge with an existing business operation.

Results of Operations and Financial Condition for the three months ended March 31, 2016,2017, as compared to the three months ended March 31, 20152016

The Company had no active business operations for the periods ended March 31, 20162017 and March 31, 2015.2016. Expenses consist of accounting and filing fees.

Liquidity and capital resources

The Company had no active business operations for the three months ended March 31, 2016.2017. Accordingly, all the Company had no liquidity and capital resources for the period.Company’s cash flow needs were provided by a related company.

Risk factors

The Company’s critical accounting policies are still being applied despite the fact that the Company has no ongoing business operations.

Significant Estimates

The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, as well as the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.
Critical accounting polices include the areas where we have made what we considered to be particularly subjective or complex judgments in making estimates and where these estimates can significantly impact our financial results under different assumptions and conditions.Accounting Policies

We prepare our financial statements in conformity with generally accepted accounting principles in the United States of America. As such, we are required to make certain estimates, judgments and assumptions that we believe are reasonable based upon the information available.historical experience, current trends and other factors. These estimates, judgments and assumptions affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the periods presented. Actual results could be different than those estimates.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

Market Risks

There has been no material change in market risks since our last Annual Report on Form 10-K for the year ended December 31, 2015.2016.

 
9


ITEM 3. 
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
 
Not Applicable
None
 
 
Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our chief executive officer and chief financial officer, evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15 under the Securities Exchange Act of 1934, as amended (Exchange Act), as of the end of the period covered by this Quarterly Report on Form 10-Q.

Based on this evaluation, our chief executive officer and chief financial officer concluded that, as of the fiscal period end, our disclosure controls and procedures are designed at a reasonable assurance level and are effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting that occurred during the quarter ended March 31, 20162017 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Limitations on Effectiveness of Controls and Procedures

In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs.

 
PART II 
10

OTHER INFORMATION
 
PART IIOTHER INFORMATIONITEM 1.
LEGAL PROCEEDINGS

ITEM 1.    LEGAL PROCEEDINGSNone

None


None
None

ITEM 3.
DEFAULTS UPON SENIOR SECURITIES

None
None
ITEM 4. 
RESERVED

ITEM 4.    RESERVED

ITEM 5. 
OTHER INFORMATION

None
None

ITEM 6. 
EXHIBITS

Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 302 of theSarbanes-Oxleythe Sarbanes-Oxley Act of 2002
32
Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section1350Section 1350


 
11

 
SIGNATURES
SIGNATURES
 
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned; thereunto duly authorized this 13th15th day of May, 2016.

2017.
 

 GREEN PLANET BIOENGINEERING CO., LTD. 
    
Date:May 13, 201615, 2017  
By:
/s/ Jordan Weingarten
 
  Jordan Weingarten
President and Chief Financial Officer 
  
(Principal Executive Officer and
Principal Financial Officer)
 


 
12

 9